Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

The building will provide storage for sports cars during the winter. Kageleiry said people sometimes don't have space to ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

Through June 8: "Lunar Phases: Korean Moon Jars" — Denver Art Museum, 100 W. 14th Ave. Parkway, Denver, go online for prices: ...

We recently compiled a list of the 15 Best EV Stocks To Buy According to Billionaires. In this article, we are going to take ...

The New York Transit Museum is rolling out its vintage NYC subway cars to transport riders to the Yankees' and Mets' opening ...

The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.

Step up to the plate and board nostalgic trains to the Mets and Yankees home-opener games this baseball season. Yankees’ fans ...

OTA updates have yet to fully realise their potential, with most still only able to update infotainment functions, dubbed ...

More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling ...

Bristol Myers Squibb buys 2seventy bio for $286 million, strengthening its cancer portfolio with Abecma CAR-T therapy for ...

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.